Skip to main content
Caplight Logo









ProArc Medical

ProArc Medical

Private
IsraelHealthcare & Life Scienceshttps://www.proarcmedical.com/

Last Round

SAFE

Jul 1, 2026

Total Funding Raised

$2.2M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

ProArc Medical is a medical device company that develops minimally invasive solutions for the treatment of benign prostatic hyperplasia (BPH).

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

medical deviceurologybenign prostatic hyperplasiaBPHminimally invasive surgeryurological implantsmen's healthsurgical platformurology devicemedtechnitinol implanturology clinicambulatory surgery centerprostate treatment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ProArc Medical Comparables

Compare ProArc Medical with similar companies based on industry and business-model similarity.

ProArc Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Prodeon Medical
89%
Butterfly Medical
88%
Zenflow
88%

ProArc Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SAFEJul 1, 2026
Series AMay 1, 2023
GrantJul 2, 2019

Key People

Founding team and executive leadership

Gilad Hizkiyahu

Chief Executive Officer

Executive Team

ProArc Medical Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 1, 2026

    $390K round led by Trendlines Agtech

  • Apr 3, 2026

    Monthly visitors grew 536% MoM, reaching 1.3K.

ProArc Medical Filings

Explore SEC and related filing metadata, where available.

ProArc Medical filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about ProArc Medical's valuation, stock price, and market status.

Is ProArc Medical a public or private company?

ProArc Medical is a private company.

What is the current stock price of ProArc Medical?

ProArc Medical is a private company with no public stock price. No recent secondary market data is available.

How much is ProArc Medical worth (valuation)?

Valuation information for ProArc Medical is not publicly available.

Can I buy ProArc Medical stock?

ProArc Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was ProArc Medical's last funding round?

ProArc Medical's most recent funding round was SAFE on July 1, 2026.

Who are the main investors in ProArc Medical?

Key investors in ProArc Medical include Horizon 2020, The Trendlines Group.

Will ProArc Medical IPO soon?

No public IPO plans have been announced for ProArc Medical.

How can I track ProArc Medical secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ProArc Medical's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersIsrael
Employee Range7
Year Founded2010
Last FundingJul 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?